Corynebacterium IMP Export Protein Mutations

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing 5′-inosine monophosphate (IMP) through microbial fermentation face challenges in achieving high yields due to inefficient export of IMP by microorganisms, limiting its application in food and medical fields.

Innovation Solution

A microorganism of the genus Corynebacterium with enhanced activity of IMP export proteins, specifically ImpE1 and ImpE2, is developed to increase the export efficiency of IMP, thereby improving production yields.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional microbial fermentation methods are used for IMP production, then the production process is simple, but the IMP yield is low due to inefficient export

Engineering Contradiction:
ImproveIMP production yieldVSAvoidmicroorganism genetic modification complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent changes the activity parameter of the IMP export protein by introducing mutations in the impE1 and impE2 genes. Specifically, multiple amino acid substitutions are made in the ImpE1 and ImpE2 proteins to enhance their export activity, thereby increasing IMP production yield without fundamentally changing the fermentation process

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates modified versions of the endogenous impE1 and impE2 genes with enhanced export activity. These mutated genes are introduced into the Corynebacterium glutamicum strain to replace or supplement the wild-type genes, effectively copying and improving the export function

Inventive Principle:
Principle #26Copying

2Productivity

If IMP export protein activity is enhanced through genetic modification, then IMP export efficiency increases, but the complexity of microorganism preparation increases

Engineering Contradiction:
ImproveIMP export efficiencyVSAvoidmicroorganism preparation difficulty
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent optimizes the amino acid sequence parameters of the ImpE1 and ImpE2 proteins by introducing specific mutations. These parameter changes enhance the proteins' export activity while maintaining their basic structure and function, achieving improved efficiency without excessive complexity in preparation

Inventive Principle:
Principle #35Parameter changes

3Productivity

If multiple mutations are introduced in ImpE1 and ImpE2 proteins, then IMP export activity is significantly enhanced, but the risk of affecting protein stability increases

Engineering Contradiction:
ImproveIMP export activityVSAvoidprotein stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent carefully selects and combines multiple mutations in the ImpE1 and ImpE2 proteins, making incremental changes to amino acid residues that are likely to affect export activity while minimizing disruptions to the overall protein structure. This approach enhances export activity while maintaining protein stability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs screening and selection processes to identify mutant strains that exhibit both enhanced export activity and maintained stability. Through iterative optimization and selection, stable high-yielding strains are obtained from the mutated genes

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS11155849B2IMP-producing microorganism and method of producing IMP using the same
Publication Date: 2021.10.26 CJ CHEILJEDANG CORP

AI summary

The present disclosure relates to a microorganism of the genus Corynebacterium producing 5′-inosine monophosphate, with an enhanced activity of an IMP export protein; a method for preparing 5′-inosine monophosphate using the same; a composition for producing 5′-inosine monophosphate; and a method for increasing export of 5′-inosine monophosphate.